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Citrullinemia is one of  the five am&oacidurias associated with the Krebs- 
Henseleit urea cycle. A long-term lymphocyte line (UM-21) derived from a 
patient with this disease and nine often clones of this line were found to have no 
activity for the enzyme argininosueeinate synthetase (AS), as demonstrated by 
their inability to grow in medium in which citrulline had been substituted for 
arginine, by their inability to incorporate arginine-C 1~ derived from eitrulline- 
C 14 into cellular protein, and by direct enzyme assay. One clone had normal or 
nearly normal argininosuccinate synthetase activity, as demonstrated by the 
same criteria. Nutritional "variants" able to grow logarithmically in medium 
containing citrulline were isolated from UM-21 and three clones. The apparent 
Kms of AS  for eitrulline in UM-21, the ten clones, the variant lines, and a 
normal line were measured and fell  into three groups: AS  in UM-21 and nine 
clones had no measurable apparent Kin for citrulline," AS in the variant cells had 
apparent Kms for citrulline of approximately 20 mM; and AS  in the normal cell 
line and one clone had apparent Kms for citrulline of O.2 mM. The data suggest 
that the defect in the eitrullinemie cell lines is due to a mutation in the structural 
gene coding for argininosuccinate synthetase. 
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INTRODUCTION 
Citrullinemia is one of the five aminoacidurias associated with the Krebs- 
Henseleit urea cycle. It is thought to be due to a deficiency in the activity of 
argininosuccinate synthetase (AS; E.C. 6.3.4.5), which catalyzes the con- 
version of citrulline and aspartic acid to argininosuccinate (Tedesco and Mell- 
man, 1967). Patients with this disease generally have a 50- to 100-fold eleva- 
tion in citrulline concentration in the serum, cerebrospinal fluid, and urine, 
but they often have normal levels of arginine and ornithine, and produce 
normal amounts of urea (McMurray et al., 1963; Mohyuddin et al., 1967; 
Morrow et al., 1957). The major manifestations of the disease are protein 
intolerance, ammonia intoxication leading to convulsions, and mental re- 
tardation. 
In July 1970, University of Michigan long-term lymphocyte line 21 
(UM-21) was established from a 33-year-old mentally retarded male (R. D.) 
with citrullinemia, citrullinuria, and a history suggestive of at least three 
episodes of ammonia intoxication during adolescence (Scott-Emuakpor 
et al., 1972). Of the ten patients with this disease described in the literature, 
R. D. has the most nearly normal ammonia metabolism. UM-21 has been in 
continuous culture since its establishment and maintains a stable 46,XY 
karyotype in 959/0 of its cells. In 1971, the parental line was cloned and ten 
clones were derived (Choi and Bloom, 1970a). 
Preliminary studies of UM-21 determined that the citrullinemic defect 
is demonstrable in long-term lymphocyte cell lines (Spector and Bloom, 
1973). In the present report, we describe the citrulline metabolism of the ten 
clones of UM-21 we studied in order to determine whether there is hetero- 
geneity within and between the clones in their ability to metabolize citrulline. 
Such heterogeneity would presumably reflect intercellular differences in 
citrulline metabolism, which would be further proof of genetic variability in 
human cell populations. 
UM-21 and the ten clones were analyzed in several ways. The ability 
of the cells to grow in medium in which citrulline was substituted for arginine 
was examined, as was their ability to take up ureido-Cl¢-citrull ine into the 
cell cytoplasm, their ability to incorporate C 14 label into trichloroacetic acid 
(TCA) precipitable protein, and their AS activity. By identifying the metabolic 
products of citrulline-C 14, we have also shown indirectly which of the urea 
cycle enzymes are present in cultured lymphocytes. Further, nutritional 
variants different from both citrullinemic and normal cells were derived from 
the citrullinemic parental lines. The data suggested that the citrullinemic defect 
in our cells was due to a mutation in the structural gene coding for arginino- 
succinate synthetase. Lastly, an explanation for the normal urea production 
observed in this citrullinemic patient is here offered. 
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MATERIALS AND METHODS 
Lymphocyte Lines 
The continuously growing lymphocyte cell lines used in these experiments 
were established by the lysate method (Choi and Bloom, 1970b). The cell 
lysates used contain the Epstein-Barr virus, which plays a role in the estab- 
lishment and continuous propagation of the lines (Moore et al., 1967). To 
date, the virus has not been shown to interfere with host cell metabolism and 
the expression of biochemical defects in these cells (Choi and Bloom, 1970b; 
E. B. Spector, unpublished). University of Michigan long-term lymphocyte 
line 43 (UM-43) was established in January 1974 from a 22-year-old normal 
male. The citrullinemic line, UM-21, was established in 1970 as described 
above. In 1971, UM-21 was cloned in microtest plates (Choi and Bloom, 
1970a) and ten clones were isolated. 
Growth Medium 
Our lymphocyte lines are routinely maintained in Roswell Park Memorial 
Institute Medium 1640 (RPMI 1640, Gibco) with 20~ fetal calf serum, plus 
60 units of penicillin per milliliter and 0.3 mg of kanomycin per milliliter. 
This medium normally contains arginine at a concentration of 1.0 raM. In the 
growth experiments, cells were incubated in two types of media: RPMI with 
1.0 mM arginine (Cit-Arg +) and RPMI with 1.0 mM citrulline substituted for 
arginine (Cit+Arg-). In toeach type of medium, approximately 0.3 x 106 
cells per milliliter from UM-43, UM-21; and UM-21 clones 1 through 10 
were inoculated. The cell concentrations were determined every 48 hr in a 
hemocytometer and viability was determined by trypan blue dye exclusion 
(Tennant, 1964). 
Autoradiography 
UM-43, UM-21, UM-21 variant, and UM-21 clones 1 through 10 were 
examined for uptake of label derived from citrulline-C 14. Approximately 
0.5 × 106 cells from each line were incubated for 48 hr in 4 ml of medium 
containing 0.52 #moles of ureido-Cl*-citrulline (specific activity 7.73 mCi/ 
mmole, New England Nuclear) and 4.0 #moles of nonradioactive citrulline 
(Sigma). The citrulline-C 14 was dissolved in Hank's balanced salt solution 
(HBSS) and stored at 4 C. The cells were harvested by washing three times 
with HBSS. They were then resuspended in 1 ml of fetal calf serum and 
placed on slides. The slides were stained with carbol fuschin and dipped in 
Kodak NTB-3 emulsion (Nakagome, 1969). After 8 days of exposure, the 
F 
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slides were developed. From each line, 800-1000 cells were analyzed and 
classified as being heavily labeled (>20 grains per cell), lightly labeled 
(11-20 grains per cell), or unlabeled (0-10 grains per cell). 
Incorporation of C ~4 Label into Cellular Protein 
Approximately 1.5 x 106 cells from UM-43, UM-21, UM-21 variant, and 
UM-21 clones 1 through 10 were inoculated into 12 ml of serum-free medium, 
which was deficient in citrulline and arginine. The cells were incubated for 
12 hr at 37 C to starve them for arginine. Cell samples were then divided into 
three equal parts and placed in three separate test tubes, each containing 4 ml 
of medium with 0.26/~moles of ureido-C14-citrulline, 4 #moles of nonradio- 
active citrulline, and 20~ fetal calf serum. The fetal calf serum contained no 
arginine and only trace amounts of citrulline (R. L. Allen, personal communi- 
cation). The cells were incubated in this medium for an additional 12 hr at 
37 C. One-fourth of each sample was used for protein determination (Lowry 
et al., 1951). The remainder of the sample was pipetted into a filter apparatus 
containing GFC glass fiber filter paper (Whatman) and was washed succes- 
sively with 40 ml each of ice-cold 0.85~ saline, 5~  TCA, and absolute 
methanol. The filter papers were allowed to air-dry, and were then placed 
in scintillation vials with 0.5 ml Soluene (Packard) and incubated overnight 
at 37 C. Ten milliliters of nonaqueous scintillation fluid (3.0 liters toluene, 
21 g PPO, and 1.8 g POPOP) was added and the amount of radioactivity 
(cpm) in the TCA precipitate was determined in a Packard Tri-Carb scin- 
tillation counter, model 3320, with a 95~ counting efficiency for ~4C. 
Activity for each sample was expressed as counts per minute per microgram 
of protein (cpm/#g protein). 
Cell Fractionation and Identification of Citrulline-C 14 Metabolites 
Approximately 1 x 106 cells from UM-43, UM-21, UM-21 variant, and 
UM-21 clone 6 were incubated in 8 ml of medium containing 0.2 #moles of 
purified citrulline-C 14 for 24 hr at 37 C. The cells were spun down and washed 
once with 0.85~ saline. The cells were harvested and analyzed using a modifi- 
cation of the method of Subramanian et al. (1973). One milliliter of cold 5~  
TCA was added to lyse the cells. The TCA-precipitable material was spun 
down, resuspended in 0.5 ml of 6 M HC1, and hydrolyzed for 24 hr at 105 C 
in a sealed, evacuated freezing ampule. The incubation medium, the TCA- 
soluble fraction (cytoplasm) of the cells, and the TCA-precipitable cell 
protein fraction were analyzed on Dowex 50-X8 (200-400 mesh) (Bio-Rad) 
columns, Na ÷ or H + form. The resin was prepared by washing it twice for 
1 hr, each time with 2 M NaOH, and then washing three times with 3 M HC1. 
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Fines were removed from the resin by washing several times with deionized 
water. The resin was packed to a volume of 7 ml in a 10-ml disposable syringe 
and equilibrated with the first buffer used for each type of column. 
Two types of  columns were used to separate the possible radioactive 
products. Arginine-C 14 was separated from citrulline-C 1~, argininosuc- 
cinate-C 14, and urea-C 14 on a Na ÷ column by eluting with 20 ml of 0.116 
M sodium citrate at p H  5.3, followed by 20-40 ml of 0.2 M NaOH.  All com- 
pounds, except the arginine-C 14, come through in the first column volume. 
The arginine-C ~4 was then eluted with 0.2 N NaOH. Fractions were collected 
and 1 ml of  each was counted in 10 ml of  aqueous scintillation fluid (2 liters 
toluene, 1 liter Triton X-100, 8 g PPO, and 0.2 g POPOP). The incubation 
medium, the hydrolyzed TCA precipitate, and the TCA-soluble material 
were run on this type of column. 
Urea-C 14 and argininosuccinate-C a4 were separated from citrulline-C ~4 
on a Dowex 50-X8 (200-400 mesh) H + column. The sample was eluted with 
10 ml of  0.1 1~ HC1, 40 ml of  1.5 M HC1, and 40-60 ml of  6.0 M HC1. Fractions 
were collected and counted as described above. Urea-C 14 and arginino- 
succinate-C ~4 eluted in 1.5 M HC1 and citrulline-C ~4 in 6 M HC1. The first 
column volume containing counts collected from the Na + column to which 
the TCA-soluble cellular material and the incubation medium had been 
applied was analyzed on the H + column. 
The H ÷ column was also used to purify the citrulline-C 14 used in the 
cell fractionation studies. When purchased commercially, the radioactive 
citrulline contains a contaminant which behaves like urea-C a4 on the columns. 
In order to remove this contaminant, the powder was dissolved in 5 ml of  
deionized water. A 0.5-ml sample of  the stock solution was placed on a H ÷ 
column and eluted as above. The first 10-20 ml of  6 M HC1 elutant was 
pooled and evaporated. The purified label was resuspended in HBSS and 
stored at 0 C. 
Assay for Argininosuccinate Synthetase Activity 
An assay has been developed to measure argininosuccinate synthetase activity 
in long-term lymphocyte cell lines (Lockridge et al., in preparation). Approxi- 
mately 0.1 mg of lysed cells was incubated with 5 mM ATP (Sigma), 0.22 
mM uniformly labeled aspartic acid-C 14 (Amersham-Searle, diluted to a 
specific activity of  20 mCi/mmole with cold aspartate), 10 mM tris-HC1 
buffer, p H  7.9, 10 mM MgC12, and 20 mM citrulline (Sigma) for 1 hr at 37 C. 
The reaction was stopped by boiling, and the product, argininosuccinate-C 14 
was allowed to convert to its anhydride form. The product was separated 
from the remainder of  the reaction mixture on a Dowex l-X8 acetate column 
by eluting with 3 ml of  0.05 M acetic acid. The entire 3-ml fraction was col- 
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Fig. 1. Growth of UM-43, UM-21, and UM-21 clone 6 in medium 
containing 1.0 mM citrulline. Approximately 3.0 × l0 s live cells per 
milliliter were inoculated into 15 or 30 ml Cit+Arg - medium. Cells 
were counted every 48 hr in a hemocytometer and cell viability was 
determined by trypan blue dye exclusion. 




All cells showed normal logarithmic growth in RPMI Cit-Arg ÷ medium, 
reaching cell densities of 1 x 106 cells per milliliter. Cells from UM-43 were 
also able to grow logarithmically in RPMI Cit+Arg - medium, while cells 
from UM-21 and nine of the clones did not grow exponentially in the medium 
(Fig. 1). However, cell densities of 0.15-0.2 × 10 6 viable cells per milliliter 
were maintained in cultures of several clones and the UM-21 parental line. 
After incubation in the Cit÷Arg - medium for 1-2 months, the cells in some 
of the cultures began to increase in number. UM-21 parental line and three 
clones (clones 2, 3, and 5) yielded cells that were able to grow in Cit+Arg - 
medium and have been maintained in this medium for over 1 year; four other 
clones (clones 1, 4, 9, and I0) yielded cells able to grow in citrulline briefly 
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that died out after 2-3 months; and two clones (clones 7 and 8) never yielded 
cells able to grow in Cit+Arg - medium. Those cells isolated from UM-21 
parent and clones 2, 3, and 5 able to utilize citrulline for growth were different 
from the parental cells from which they were isolated and were referred to as 
"variant" cells. One clone, clone 6, was able to grow logarithmically in Cit ÷ 
Arg-  medium like the normal UM-43 cells (Fig. 1). 
Incorporation of  C 14 Label into Cellular Protein 
Autoradiography was used to demonstrate the incorporation of the C ~4 label 
derived from citrulline-C 14 into cellular protein (Table I). C 14 label in free 
pools of citrulline and in asparaginyl tRNA was washed out of the cells when 
they were stained with carbol fuschin. UM-43 had 87% of its cells heavily 
labeled. UM-21 and nine clones had no labeled cells. UM-21 variant and 
UM-21 clone 6 showed a labeling pattern somewhat different from that of 
UM-43. The UM-21 variant line had 37% of cells with no label, 39% with 
light label, and 24% with heavy label. Clone 6 had 6% of cells with no label, 
2 2 ~  with light label, and 72% with heavy label. 
Studies of the extent of incorporation of C 1. label derived from ureido- 
C~4-citrulline into TCA-precipitable cellular protein gave results similar 
to the autoradiography (Table II). The experiments were done in four groups, 
each group consisting of three citrullinemic cultures and one control culture, 
UM-4Y The numbers represent the averages of triplicate samples. A Dun- 
news t test was used to test for significant differences between the mean 
activities of the mutant cultures and the mean activity of the control culture 
in each experimental group (Steel and Torrie, 1960). The tests were done 
using the logarithms of the activities, which equalizes the variances of the 
small and large numbers and normalizes the distribution of the activities for 
Table I. Incorporation of C 14 Label Derived from Citrulline-C 14, into 
Normal (UM-43) and Mutant (UM-21) Human Lymphocyte Lines, as 
Visualized by Autoradiograpby 
Percent of cells containing specified 
number of silver grains 
Cell type > 20 11-20 0-10 
UM-43 (normal) 87 12 1 
UM-21 (citrullinemic) 0 0 100 
UM-21 (9 clones) 0 0 100 
UM-21 (variant) 24 39 37 
UM-21 (clone 6) 72 22 6 
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Table II. Total Radioactivity Incorporated into Cell Protein of 
Human Lymphocyte Lines Grown in Citrulline-C 14 for 12 hr 
Activity 
(cpm//lg protein) 
Experiment Cell line Average Range 
I Clone 1 48 (27-70) 
Clone 2 98 (88-119) 
Clone 3 32 (11-43) 
UM-43 116 (99-148) 
II Clone 4 89 (70-125) 
Clone 5 12 (9-16) 
Clone 6 106 (80-142) 
UM-43 289 (154-355) 
III Clone 7 20 (5-36) 
Clone 8 3 (2-4) 
Clone 9 4 (2-7) 
UM-43 162 (140-193) 
IV Clone 10 18 (4-45) 
UM-21 6 (3-9) 
UM-21 variant 43 (20-72) 
UM-43 294 (258-346) 
the control and citrullinemic lines, thereby eliminating the effects of log- 
arithmic cell growth. Cells from clones 2, 6, and 7 and UM-21 variant had 
activities not significantly different from that of  the UM-43 normal control 
(p < 0.05). 
Cell Fractionation and Identification of  Citrulline-C 14 Metabolites 
Analysis of protein hydrolysates from UM-43, UM-21, UM-21 variant, and 
UM-21 clone 6 on Dowex 50-X8 Na ÷ columns demonstrated that the radio- 
active material seen on autoradiography and in the TCA-precipitable 
material was arginine-C ~4. No other radioactive products were detected in 
the hydrolyzed protein. Over 24 hr, UM-43 incorporated an average of 1.39 
nmoles of  arginine-C 14 into protein while UM-21 incorporated no radio- 
activity into cellular protein. UM-21 variant and UM-21 clone 6 incorporated 
0.04 and 0.55 nmoles of  arginine-C 1¢, respectively (Table III). 
The TCA-soluble cell material was analyzed for pools of free citrulline- 
C 14, argininosuccinate-C 14, arginine-C ~4, and urea-C 14. After running the 
samples on both Na ÷ and H + Dowex 50-X8 columns, it was found that all 
of the radioactive material in the TCA-soluble fraction was citrulline-C ~4. 
I t  is not possible at this time to determine if the citrulline-C 14 found in this 
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Table I IL Amount  of  Al"ginine-C 1~ Derived 
f rom Citrulline-C 14 Incorporated into TCA- 
Precipitable Cell Protein of  Long-Term 
Lymphocyte Lines in Cell Fractionation 
Experiment 
Arg-C I4 in protein 
Cell line (nrnoles) 
UM-21 0 
UM-21 variant 0.04 
UM-21 clone 6 0.55 
UM-43 1.39 
Table IV. Apparent  K., of  Argininosuccinate Syn- 
thetase for Citrulline in Citrullinemic (UM-21) and 
Normal  (UM-43) Long-Term Lymphocyte Lines 
Line Medium Km (mM) 
UM-21 Cit -Arg  + __a 
Um-21 variant Cit +Arg - 26 b 
Clone 1 C i t -Arg  + - - "  
Clone 2 C i t -Arg  + a 
Clone 2 variant Cit + Arg - 19 b 
Clone 3 C i t -Arg  + - - .  
Clone 3 variant Cit+Arg - 13 b 
Clone 4 C i t -Arg  + - - a  
Clone 5 C i t -A rg  + - - "  
Clone 5 variant Cit+Arg - 26 b 
Clone 6 C i t -A rg  + 0.2 c 
Clone 6 C i t + A r g -  0.2 c 
Clone 7 C i t -Arg  + __a 
Clone 8 C i t -Arg  + - - .  
Clone 9 C i t -Arg  + - - .  
Clone 10 C i t -A rg  + 
UM-43 Cit -Arg  + 0.2 c 
UM-43 Cit +Arg - 0.2 c 
a Not  detectable. 
b The concentrations of  citrulline used ranged from 
5 to 300 raM. The apparent K,, of  AS for citruUine 
was estimated f rom a Lineweaver-Burk plot. 
c The concentrations of  citrulline used ranged f rom 
0.1 to 20 mM. The apparent  Km of AS for citrulline 
was estimated using a Lineweaver-Burk plot. 
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fraction was in the cell cytoplasm or was trapped in the interstitial water 
between the cells during centrifugation. 
The medium in which the cells were growing was also analyzed for the 
presence of citrulline-C 14 , argininosuccinate-C 14 , arginine-C ~4 , and urea-C ~4. 
Only unmetabolized citrulline-C ~4 was found. 
Enzyme Assays 
Assays done on UM-43, UM-21 variant, and UM-21 clones 1 through 10 
growing in Ci t :Arg + medium showed that only UM-43 and UM-21 clone 6 
had detectable AS activities (Table IV). The apparent K m of AS for citrulline 
was measured in all 13 lines growing in Cit-Arg + medium and in all lines 
derived from UM-21 parent and UM-21 clones 2, 3, 5, and 6 growing in 
Cit+Arg - medium. The AS in the lines fell into three groups: AS with no 
measurable apparent K m for citrulline, AS with an apparent K m for citrulline 
of approximately 20 raM, and AS with an apparent Km for citrulline of 0.2 
raM. UM-21 and nine of the clones growing in Ci t -Arg + medium had no 
measurable AS activity at concentrations of citrulline up to 0.3 M in the assay 
mixture; therefore, the apparent Km of AS for citrulline in these lines was 
unmeasurable. AS in UM-43 and UM-21 clone 6 growing in both Cit+Arg - 
medium and Cit-Arg + medium had similar apparent KmS for citrulline of 
0.2 mM. The apparent Kms of AS for citrulline in the variant cells derived 
from UM-21 parent and clones 2, 3, and 5 growing in Cit+Arg - medium 
were approximately 20 raM. 
DISCUSSION 
UM-21 has essentially no AS activity, as shown by its inability to grow 
logarithmically in Cit+Arg - medium, by its inability to take up labeled 
citrulline on autoradiography, and by enzyme assay. Under long-term 
selection in medium containing citrulline, a variant line arose that could 
utilize citrulline for growth. This "variant" has significant AS activity, as 
demonstrated by its ability to grow in Cit+Arg - medium, to take up labeled 
citrulline on autoradiography, and to convert labeled citrulline to arginine 
incorporated into protein. It also has detectable AS activity with a measurable 
apparent K m for citrulline. 
The ten clones of UM-21 seem to be heterogeneous in their ability to 
metabolize citrulline. Clone 6 is very different from the other clones of 
UM-21 in that it has essentially normal AS activity. It can grow exponentially 
in Cit+Arg - medium, it takes up and incorporates approximately the same 
amount of citrulline-C 14 into arginine in protein as the normal cells, and its 
AS has the same apparent K,, for citrulline as AS in normal cells. Three 
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clones (2, 3, and 5) gave rise to lines which were able to utilize citrulline for 
growth after a 1- to 2-month incubation in Cit+Arg - medium. The apparent 
/(ms of AS for citrulline in these variant lines are 13-26 raM, as opposed to 
no measurable apparent Km of AS for citrulline in the parental clones from 
which they were derived. The remaining six clones died out completely in 
Cit+Arg - medium and did not yield lines able to utilize citrulline for growth. 
Two of these six clones never gave rise to variant cells, while four clones gave 
rise to variant cells that remained viable only for 2-3 months. Three classes 
of clones were found then: six clones which had no cells with AS activity, 
three clones which had no AS activity but which produced cells capable of 
utilizing citrulline for growth when incubated in Cit+Arg - medium, and 
one clone, clone 6, which had normal or nearly normal AS activity. 
Determination of the origin of the variant cells selected from the UM-21 
parental line and clones 2, 3, and 5 poses a very interesting problem. These 
variant cells could be the result of an entire cell population's adapting to 
citrulline in the growth medium over a period of 1 month. Alternatively, 
they could have originated from a few cells which had mutated from AS- 
to AS + in the parental population and were then selected for in the Cit+Arg - 
medium. 
Jacoby (1974) found that long-term lymphocyte lines derived from var- 
ious donors with no defects in urea cycle enzymes exhibited a lag of 24 hr 
to 3 weeks before exponential growth began when transferred from medium 
containing arginine to medium containing citrulline. Lines which adapted 
within 2-3 days after being transferred to citrulline seemed to have been 
exhibiting a uniform adaptation of the entire cell population. The lag time 
was consistent within lines and their clones when tested several times. The 
lines also had the same cloning efficiency in both arginine-containing and 
citrulline-containing growth medium, although it took somewhat longer for 
clones to appear in citrulline-containing medium. The adaptation was 
accompanied by a significant increase in the AS activity. Jacoby suggested 
that the short lag period found in some lines and the consistency of the length 
of the lag period within lines and their clones argued for adaptation of the 
whole cell population to citrulline as opposed to selection of mutant cells 
able to utilize citrulline for growth in the original cell population. 
The mutant hypothesis is supported by studies of the enzyme asparagine 
synthetase in a variety of tumor cell lines including Jensen sarcoma cells, 
Gardner's lymphosarcoma cells, Walker 256 carcinosarcoma cells, and mouse 
leukemia L5178Y ceils (Wriston and Yellin, 1972). These cells were all 
sensitive to asparaginase and required asparagine for growth because they 
lacked asparagine synthetase activity. When the ceils were placed in medium 
containing no asparagine, their number declined rapidly for 10 days and then 
the cells began to multiply and eventually entered a logarithmic growth cycle. 
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These cells no longer required asparagine for growth and have been shown 
to have asparagine synthetase activity. Using Jensen sarcoma cells, Patterson 
et al. (1969) determined that two cell populations were present originally. 
They noted that, although the majority of the cells were dying, the uptake of 
thymidine-H 3 and the number of cells in mitosis increased daily. Extrapola- 
tion of the growth curve from the time when the cells began to increase in 
number to zero time showed a cell doubling time of 36 hr for approximately 
100 cells able to grow without asparagine present in the 1 x 106 cells originally 
seeded. Cloning experiments further supported the hypothesis that the variant 
cells preexisted in the parental population and were not a result of adaptation 
of the entire cell population to the lack of asparagine in the medium. Other 
cloning experiments have shown that almost all tumor cell lines and their 
clones can eventually give rise to cells able to grow without asparagine. 
Morrow (1971) and Summers and Handschumacher (1973) used a Luria- 
Delbriick fluctuation analysis to provide statistical evidence that cells with 
asparagine synthetase activity preexisted in the Walker 256 rat carcino- 
sarcoma lines and the L5178Y mouse leukemia line. In both investigations, 
it was found that the cells able to grow without asparagine preexisted in the 
tumor cell population and therefore were not induced by growth in aspar- 
agine-deficient medium. 
The situation with our cell lines is similar to that in the tumor cells in 
that we are looking for the appearance of cells with activity for an enzyme 
in a population of cells devoid of it (AS- ~ AS + events). Cells with AS 
activity can be isolated from the parental line and three of nine clones. One 
clone, clone 6, isolated from the parental line has normal AS activity and 
can grow equally well in Cit-Arg ÷ medium or Cit+Arg - medium. The cells 
with AS activity are stable and retain their ability to grow in Cit÷Arg - 
medium. It took 4-8 weeks to select for cells able to grow without exogenous 
arginine. This may be due to the fact that the frequency of AS ÷ cells was 
lower than the 1 in 104 that was found in the Jensen sarcoma cells. The 
striking similarity between our results and those found with asparagine 
synthetase in the tumor cell lines strongly suggests that the variant ceils we 
isolated originated as spontaneous mutations from AS-  to AS + . In addition, 
if the variant cells arose by adaptation or activation of argininosuccinate 
synthetase, one would expect the apparent K,, of AS for citrulline to be the 
same in the adapted variant cells as it is in normal UM-43 cells. In this case, 
the apparent Km of AS for citrulline in the variant cells was 100 times greater 
than in the normal cells. In order to determine specifically if the AS + variant 
cells that were selected were produced by adaptation to citrulline or by 
mutation, a fluctuation analysis should be done on the parental line and the 
clones. 
If mutations from AS-  to AS + occur in vitro, as they seem to have in 
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some clones of UM-21, they might also occur in vivo. It is possible that R. D. 
himself is a mosaic composed largely of ceils having no AS activity but with 
a small population of cells that do have activity. The UM-21 parental line 
might have been established from a heterogenous population of cells, with 
the UM-21 variant cells representing the subpopulation of cells with AS 
activity. If R. D. is in fact a biochemical mosaic, it would explain his ability 
to tolerate a normal protein intake and to synthesize urea, without proposal 
of the existence of an alternate urea-synthesizing pathway as others have 
done (Scott-Emuakpor et al., 1972). 
The cell fractionation studies give some information about which 
enzymes of the urea cycle are present in long-term lymphocyte lines. The 
results of these studies demonstrated that normal lymphocytes (UM-43), 
UM-21 variant, and UM-21 clone 6 have argininosuccinate synthetase and 
argininosuccinate lyase activity since they were capable of converting 
citrulline-C ~4 to arginine-C 14. UM-21 did not have this capability, since 
no labeled arginine could be found in its protein fraction. No urea-C 14 was 
found in any of the cell fractions examined, indicating that there was no 
detectable arginase activity under the conditions of the experiment. 
Some information concerning the nature of the defect in this citrul- 
linemic line can be deduced from these experiments. The defect could be 
due to a deletion of a structural gene coding for the enzyme or a regulatory 
protein, to a defect in the transportation ofcitrulline across the cell membrane, 
to a point mutation in the gene coding for the enzyme protein leading to a 
loss of activity and/or instability of the enzyme, or to a point mutation in a 
regulatory gene leading to decreased synthesis or increased degradation of a 
normal enzyme protein. 
The existence of cells with AS activity such as the variant cells and clone 
6 cells strongly suggests that the mutation is not due to a deletion of a 
structural or regulatory gene, whether the AS + cells were preexisting or 
arose by mutation. 
The defect is probably not in the transport of citrulline across the cell 
membrane, although further studies would have to be done to rule this out 
completely. 
The data suggest that the citrullinemic defect is due to a mutation in a 
regulatory gene or in the structural gene coding for AS. Other investigators 
have used differences in physical properties between enzymes isolated from 
normal cells and enzymes isolated from variant cells as evidence of a mutation 
in a structural gene leading to an altered protein product. The criteria that 
have been used include heat lability (Chasin et al., 1974; Sharp et  al., 1973), 
sensitivity to inhibitors (Albrecht et  al., 1972; Chan et  al., 1972), immuno- 
logical cross-reactivity (Beaudet et al., 1973), and kinetic properties (Sharp 
et  al., 1973). The fact that the apparent K,,s of AS for citrulline in the variant 
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cells selected f rom UM-21 parental line and in clones 2, 3, and 5 are different 
f rom the apparent  K m of  AS for citrulline in normal  cells (UM-43) and the 
fact that  AS in clone 6 has an apparent  K m for citrulline which is different 
f rom that o f  the variant cells strongly suggest the mutat ion present in UM-21 
is in the structural gene coding for AS. I f  the mutat ion in UM-21 were in a 
regulatory gene, then the second mutation,  present in the variant cells and 
restoring enzyme activity, would probably be in the regulatory gene or in 
some gene involved in its translation. Under  these conditions, AS in the 
variant cells should have the same apparent  Km for citrulline as AS in normal  
cells. An  ant ibody to human AS that cross-reacts with AS f rom mutant  cells 
would help to distinguish between the two alternatives. By precipitating the 
AS with the antibody, one could determine how much enzyme protein is 
present and whether or not  it is active. I f  there is a small amount  o f  active 
enzyme present in the UM-21 cells, then one could presume a regulatory gene 
mutation.  Alternatively, if there are normal  amounts  o f  an inactive protein 
present, one may then assume that the basic defect is a mutat ion in the enzyme 
protein leading to a change in the active site, with a consequent loss of  activity. 
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